Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatment

Bone

Volumn 40, Issue 2, 2007, Pages 516-521

  Mitterbauer, Christa ^a   Kramar, Reinhard ^b,c   Oberbauer, Rainer ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hospital of Wels   (Austria)

^c Austrian Dialysis and Transplant Registry ^*  (Austria)

Author keywords

Bone; Fracture; Hemodialysis; Logistic regression model; Prediction rule

Indexed keywords

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; AUSTRIA; BIOCHEMISTRY; CALCULATION; CALIBRATION; DATA BASE; DEMOGRAPHY; EVALUATION; FEMALE; FRACTURE; GENDER; HEMODIALYSIS; HOSMER AND LEMESHOW GOODNESS OF FIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PROBABILITY; RISK FACTOR; ROC CURVE; STATISTICAL ANALYSIS; VALIDATION PROCESS;

AGED; AGING; FEMALE; FRACTURES, BONE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SEX FACTORS;

EID: 33846095863     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.09.017     Document Type: Article

References (20)

1. U.S. Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005.
2. Haas M., Leko-Mohr Z., Roschger P., Kletzmayr J., Schwarz C., Domenig C., et al. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. Am. J. Kidney Dis. 39 (2002) 580-586
3. Zonana-Nacach A., Barr S.G., Magder L.S., and Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 43 (2000) 1801-1808
4. de Deus R.B., Ferreira A.C., Kirsztajn G.M., and Heilberg I.P. Osteopenia in patients with glomerular diseases requiring long-term corticosteroid therapy. Nephron, Clin. Pract. 94 (2003) c69-c74
5. Holmberg A.H., Johnell O., Nilsson P.M., Nilsson J.A., Berglund G., and Akesson K. Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women. Osteoporos. Int. 16 (2005) 2185-2194
6. de Liefde I., van der Klift M., de Laet C.E., van Daele P.L., Hofman A., and Pols H.A. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos. Int. 16 (2005) 1713-1720
7. Heidrich F.E., Stergachis A., and Gross K.M. Diuretic drug use and the risk for hip fracture. Ann. Intern. Med. 115 (1991) 1-6
8. Johansen K.L. Testosterone metabolism and replacement therapy in patients with end-stage renal disease. Semin. Dial. 17 (2004) 202-208
9. R. Kramar, H. Stummvoll, Österreichisches Dialyse-und Transplantationsregister, ÖDTR, Annual Data Report of the Austrian Society of Nephrology 2004.
10. Genant H.K., Jergas M., Palermo L., Nevitt M., Valentin R.S., Black D., et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11 (1996) 984-996
11. Homser D.W., and Lemeshow S. Applied Logistic Regression. 2nd ed. (2000), John Wiley and Sons, New York
12. Good P.I. Resampling Methods: A Practical Guide to Data Analysis. 3rd ed. (2005), Birkhäuser
13. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis. 42 (2003) S1-201
14. Prevention of Falls Network Europe: Hip Fracture Data Review; 2003.
15. Alem A.M., Sherrard D.J., Gillen D.L., Weiss N.S., Beresford S.A., Heckbert S.R., et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 58 (2000) 396-399
16. Atsumi K., Kushida K., Yamazaki K., Shimizu S., Ohmura A., and Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am. J. Kidney Dis. 33 (1999) 287-293
17. Coco M., and Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am. J. Kidney Dis. 36 (2000) 1115-1121
18. Stehman-Breen C.O., Sherrard D.J., Alem A.M., Gillen D.L., Heckbert S.R., Wong C.S., et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int. 58 (2000) 2200-2205
19. Danese M.D., Kim J., Doan Q.V., Dylan M., Griffiths R., and Chertow G.M. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am. J. Kidney Dis. 47 (2006) 149-156
20. Mittalhenkle A., Gillen D.L., and Stehman-Breen C.O. Increased risk of mortality associated with hip fracture in the dialysis population. Am. J. Kidney Dis. 44 (2004) 672-679